Late Onset Atypical Pantothenate-Kinase-Associated Neurodegeneration
Introduction. Pantothenate-kinase-associated neurodegeneration (PKAN) is a rare genetic disease and a form of neurodegeneration with brain iron accumulation (NBIA). It most commonly begins in the first two decades of life but should be considered in the differential diagnosis of patients at any age...
Main Author: | Natalie Diaz |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2013-01-01
|
Series: | Case Reports in Neurological Medicine |
Online Access: | http://dx.doi.org/10.1155/2013/860201 |
Similar Items
-
Clinical Heterogeneity of Atypical Pantothenate Kinase-Associated Neurodegeneration in Koreans
by: Jae-Hyeok Lee, et al.
Published: (2016-01-01) -
Atypical pantothenate kinase-associated neurodegeneration with variable phenotypes in an Egyptian family
by: Ali S. Shalash, et al.
Published: (2021-07-01) -
Novel Compound Heterozygous Mutations in the Pantothenate Kinase 2 Gene in a Korean Patient with Atypical Pantothenate Kinase Associated Neurodegeneration
by: Sung-Hyouk Kim, et al.
Published: (2009-05-01) -
Proposed Therapies for Pantothenate-Kinase-Associated Neurodegeneration
by: Suzanne Jackowski
Published: (2019-05-01) -
Precision medicine in pantothenate kinase-associated neurodegeneration
by: Mónica Alvarez-Cordoba, et al.
Published: (2019-01-01)